A detailed history of Graypoint LLC transactions in Mckesson Corp stock. As of the latest transaction made, Graypoint LLC holds 968 shares of MCK stock, worth $509,109. This represents 0.03% of its overall portfolio holdings.

Number of Shares
968
Previous 1,005 3.68%
Holding current value
$509,109
Previous $586,000 18.43%
% of portfolio
0.03%
Previous 0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$479.06 - $630.38 $17,725 - $23,324
-37 Reduced 3.68%
968 $478,000
Q2 2024

Jul 31, 2024

BUY
$518.81 - $607.81 $90,272 - $105,758
174 Added 20.94%
1,005 $586,000
Q1 2024

May 02, 2024

BUY
$473.42 - $539.26 $23,671 - $26,963
50 Added 6.4%
831 $446,000
Q4 2023

Jan 29, 2024

BUY
$437.42 - $470.64 $43,304 - $46,593
99 Added 14.52%
781 $361,000
Q3 2023

Oct 26, 2023

BUY
$402.4 - $446.42 $41,849 - $46,427
104 Added 17.99%
682 $296,000
Q2 2023

Jul 21, 2023

BUY
$354.01 - $427.31 $204,617 - $246,985
578 New
578 $246,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $75.6B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Graypoint LLC Portfolio

Follow Graypoint LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graypoint LLC, based on Form 13F filings with the SEC.

News

Stay updated on Graypoint LLC with notifications on news.